Special Issue Article
Predicting Gynecological Malignancy at Surgery: Magic 8 Ball, or Paradigm Shift?
|Hector O Chapa*|
|Medical Director, Women's Specialty Ctr, Dallas, Minimally invasive gynecologic surgery, USA|
|Corresponding Author :||Hector O Chapa
Medical Director, Women's Specialty Ctr
Dallas, Minimally invasive gynecologic surgery, USA
Tel: +1 214-841-9222
E-mail: [email protected]
|Received March 12, 2014; Accepted April 29, 2014; Published May 01, 2014|
|Citation: Chapa OH (2014) Predicting Gynecological Malignancy at Surgery: Magic 8 Ball, or Paradigm Shift?. J Clin Case Rep S1:009. doi:10.4172/2165-7920.S1-009|
|Copyright: © 2014 Chopr O H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
In medical school, future physicians are taught the phrase "primum non nocere", first do no harm. That adage motivates every physician, every healthcare provider, to go to great lengths to avoid an incorrect diagnosis for a patient. As a gynecological surgeon, that adage is put to the test with every operative patient dealing with a pelvic mass. Encountering an undiagnosed malignancy during and anticipatedbenign surgical intervention is stressful for the surgeon, but devastating to the unprepared patient. Recently, attention has focused on uterine morcellation at time of laparoscopic hysterectomy. Stemming from the inadvertent morcellation of a leiomyosarcoma in a patient presumed to have been benign fibroids, the question has arisen of informed consent disclosures versus the appropriateness of a selected surgery when the possibility of a malignancy exists (WSJ Dec 2013).